The Cancer program at TRI brings together scientists and clinicians with a shared interest and expertise in cancers such as squamous cell carcinoma, breast cancer, prostate cancer, skin cancer, melanoma and metastatic disease.

Researchers use techniques that “mimic” human cancer pathogenesis to examine the establishment and progression of disease. This allows basic research investigations to be translated into clinical trials to address significant clinical questions, and potentially trial new therapies or diagnostics. Specialised cancer groups such as IHBI Cancer program led by Professor Judith Clements aims to understand more clearly the molecular and cellular basis for the development, progression, and metastasis of several cancers. This includes other hormone dependent cancers such as those of the reproductive and urogenital organs, breast, ovary, endometrium, and kidney, as well as skins, lung, blood, and head and neck cancers. melanoma and lung cancer.

Key Researchers
Andrew Perkins
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Nicholas Andrew Saunders
Show More ...
Click a program below to learn more
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Proving the link between High stress & a Poor immune System Proving the link between high stress and ill health and disease is becoming increasingly important particularly when it comes to...Read more
Researchers show aspirin added to cancer drug improves effectiveness Adding aspirin to some existing cancer drugs could increase their effectiveness against a group of tumours resistant to treatment...Read more
Dr Roberta Mazzieri wins funding from the cure brain cancer Five of Australia’s brightest researchers, including TRI based UQDI researcher Dr Roberta Mazzieri, can now focus solely on curing...Read more
Brisbane Cancer Conference Welcome to the 3rd Brisbane Cancer Conference. With the establishment of the Brisbane Diamantina Health Partners, this meeting is an opportunity to draw together cancer...Read more
Proton beam therapy: state-of-the-art technology to target cancer. Clinical outcomes and current status in Japan Presented by Tetsuo Akimoto, Head of the Department of Radiation Oncology and Particle...Read more
TRI EMT and Cancer Treatment Symposium Leveraging on the availability of key national translational clinician researchers with EMT interests (Drs Andy Redfern, Elgene Lim), and particularly the head...Read more
MATER RESEARCHER IDENTIFIES NEW INSIGHTS INTO BREAST CANCER TREATMENTS AND PROGNOSIS A Mater Research study 1 has identified a method to identify best treatment options for oestrogen receptor...Read more
Australian Skin and Skin Cancer Research Centre (ASSC) Enabling Grant Scheme The Australian Skin and Skin Cancer Research Centre (ASSC) Enabling Grant Scheme is currently open for applications. The...Read more
Dr Jyotsna Batra wins cure cancer award 2016 TRI Spore Grant winner , QUT’s Dr Jyotsna Batra, won a Cure Cancer award last night at the Australia's Researcher Showcase and 50th birthday...Read more